[go: up one dir, main page]

FI964604L - Menetelmä ja reagensseja nivelreuman hoitamiseksi - Google Patents

Menetelmä ja reagensseja nivelreuman hoitamiseksi Download PDF

Info

Publication number
FI964604L
FI964604L FI964604A FI964604A FI964604L FI 964604 L FI964604 L FI 964604L FI 964604 A FI964604 A FI 964604A FI 964604 A FI964604 A FI 964604A FI 964604 L FI964604 L FI 964604L
Authority
FI
Finland
Prior art keywords
reagents
rheumatoid arthritis
treating rheumatoid
treating
arthritis
Prior art date
Application number
FI964604A
Other languages
English (en)
Swedish (sv)
Other versions
FI964604A7 (fi
FI964604A0 (fi
Inventor
Dennis A Carson
Albani Salvatore
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of FI964604A0 publication Critical patent/FI964604A0/fi
Publication of FI964604A7 publication Critical patent/FI964604A7/fi
Publication of FI964604L publication Critical patent/FI964604L/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/395Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245Escherichia (G)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/70539MHC-molecules, e.g. HLA-molecules
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/04Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyrane Compounds (AREA)
FI964604A 1994-05-20 1995-04-24 Menetelmä ja reagensseja nivelreuman hoitamiseksi FI964604L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24698894A 1994-05-20 1994-05-20
PCT/US1995/004896 WO1995031984A1 (en) 1994-05-20 1995-04-24 Method and reagents for the treatment of rheumatoid arthritis

Publications (3)

Publication Number Publication Date
FI964604A0 FI964604A0 (fi) 1996-11-18
FI964604A7 FI964604A7 (fi) 1997-01-15
FI964604L true FI964604L (fi) 1997-01-15

Family

ID=22933053

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964604A FI964604L (fi) 1994-05-20 1995-04-24 Menetelmä ja reagensseja nivelreuman hoitamiseksi

Country Status (11)

Country Link
EP (1) EP0762881B1 (fi)
JP (1) JPH10500679A (fi)
AT (1) ATE261735T1 (fi)
AU (1) AU696646B2 (fi)
CA (1) CA2188582A1 (fi)
DE (1) DE69532714T2 (fi)
FI (1) FI964604L (fi)
HU (1) HU220101B (fi)
NO (1) NO320773B1 (fi)
NZ (1) NZ284914A (fi)
WO (1) WO1995031984A1 (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7094597B1 (en) 1994-05-20 2006-08-22 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
US5773570A (en) * 1994-05-20 1998-06-30 The Regents Of The University Of California Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
US6989146B2 (en) 2000-08-09 2006-01-24 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
US7608683B2 (en) 2000-08-09 2009-10-27 The Regents Of The University Of California Stress proteins and peptides and methods of use thereof
US7301005B2 (en) 2000-11-01 2007-11-27 Salvatore Albani Immunomodulatory peptides derived from heat shock proteins and uses thereof
DK1964570T3 (da) 2007-03-02 2012-12-17 Protectimmun Gmbh Farmaceutisk sammensætning til beskyttelse mod allergier og inflammatoriske sygdomme
DE202007003266U1 (de) 2007-03-02 2008-07-17 Bufe, Albrecht, Prof. Dr. Med. Pharmazeutische Zusammensetzung zum Schutz vor Allergien und entzündlichen Erkrankungen
EP2346512A1 (en) * 2008-08-16 2011-07-27 Protectimmun GmbH Composition for prevention and treatment of allergic and/or inflammatory diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732757A (en) * 1978-02-06 1988-03-22 Stolle Research And Development Corporation Prevention and treatment of rheumatoid arthritis
CA2056450A1 (en) * 1989-05-31 1990-12-01 Dennis A. Carson Method to treat rheumatoid arthritis

Also Published As

Publication number Publication date
FI964604A7 (fi) 1997-01-15
HU220101B (hu) 2001-10-28
DE69532714T2 (de) 2005-03-10
NO320773B1 (no) 2006-01-23
DE69532714D1 (de) 2004-04-22
AU696646B2 (en) 1998-09-17
FI964604A0 (fi) 1996-11-18
JPH10500679A (ja) 1998-01-20
HU9603214D0 (en) 1997-01-28
NO964910L (no) 1996-11-19
EP0762881B1 (en) 2004-03-17
ATE261735T1 (de) 2004-04-15
WO1995031984A1 (en) 1995-11-30
EP0762881A4 (en) 1999-05-06
MX9605692A (es) 1998-05-31
HUT76359A (en) 1997-08-28
NO964910D0 (no) 1996-11-19
AU2360095A (en) 1995-12-18
EP0762881A1 (en) 1997-03-19
NZ284914A (en) 2000-08-25
CA2188582A1 (en) 1995-11-30

Similar Documents

Publication Publication Date Title
FI973378A0 (fi) Laite ja menetelmä
NO965489D0 (no) Kontrollert denitrifikasjonsprosess og system
FI954134A7 (fi) Järjestelmä ja menetelmä nesteen käsittelemiseksi
ATE217103T1 (de) Verfahren und vorrichtung mit bedingtem zugang
DE69434996D1 (de) Systemsteuerungsverfahren und Vorrichtung
FI955247A7 (fi) Menetelmä ja laitteisto massan käsittelemiseksi
DE69515822D1 (de) Verfahren und Vorrichtung zur inkrementalen Übertragung von Zugangsrechten
KR960701078A (ko) Dna 서열화 방법과 그 장치
FI972260A7 (fi) Laite ja menetelmä pintojen käsittelemiseksi
FI953774A7 (fi) Menetelmä ja laite vaahdotuserotteluun
BR9505734A (pt) Método para tratar gases residuais e aparelho para executar o método
FI954119A7 (fi) Menetelmä kiinteän jätteen käsittelemiseksi
FI960822A0 (fi) Laite lietteen ominaisuuksien määräämiseksi ja menetelmä lietteen käsittelemiseksi
FI952735A7 (fi) Laitteisto ja menetelmä tavaroiden vastaanottamista varten
FI962538L (fi) Menetelmä ja laite nesteiden käsittelemiseksi
FI954499L (fi) Menetelmä ja analyysi
FI943895L (fi) Paperinvalmistusmenetelmä ja menetelmän toteuttava laitteisto
FI925064A7 (fi) Menetelmä ja laitteisto bioaffiniteettimäärityksiä varten
KR970703146A (ko) 류마티스성 관절염의 치료방법 및 시약(method and reagents for the treatment of rheumatoid arthritis)
FI98653C (fi) Lauhteenpoistolaitteisto ja menetelmä lauhteen poiston säädössä
FI964604L (fi) Menetelmä ja reagensseja nivelreuman hoitamiseksi
FI941414A7 (fi) Menetelmä ja laitteisto bioproteiinien valmistamiseksi
FI932159L (fi) Menetelmä ja laitteisto näytteen ottamiseksi
FI943194A7 (fi) Menetelmä ja laite cannelonin valmistamiseksi
FI954769A0 (fi) Menetelmä ja laite prosessivalvontaa varten